Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05665725. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT03772288. IPD Sharing: YES. Countries: 2. Publications: 0.
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT06420089. IPD Sharing: NO. Countries: 1. Publications: 0.
HMPL-760 in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05190068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
ClinicalTrials.gov study NCT06534437. IPD Sharing: NO. Countries: 4. Publications: 0.
A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05127811. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04234048. IPD Sharing: NO. Countries: 1. Publications: 0.
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
ClinicalTrials.gov study NCT06098430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission
ClinicalTrials.gov study NCT05502250. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00250861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT03505996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study
ClinicalTrials.gov study NCT05191225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory
ClinicalTrials.gov study NCT04702425. IPD Sharing: NO. Countries: 9. Publications: 0.
Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous L
ClinicalTrials.gov study NCT00275080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00562380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
ClinicalTrials.gov study NCT07222345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT02928510. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma
ClinicalTrials.gov study NCT00384553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Brentuximab Vedotin, Cyclosporine, and Verapamil Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT03013933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor With ICE Chemotherapy in Secondary Central Nervous System Involving B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06552559. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.